
    
      The study is performed to provide a better understanding of the influence of biofilms on
      ureteral stents on the entire spectrum of stent-associated morbidity in a longterm setting.

      In addition, the trial is intended to give an overview of the incidence of complaints, the
      occurrence of complications and their economic aspects.

      The influence of biofilms on the morbidity associated with longterm ureteral stenting is
      assessed.
    
  